Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pylopass for H. pylori carriers with mild indigestion
NCT02051348Phase 3Completed
- Sponsor
- Atlantia Clinical Trials
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial (2 arms), sponsored by Atlantia Clinical Trials. Primary endpoint: Efficacy of Pylopass to reduce H pylori load by urease breath test up to 8 weeks. Started Jan 2014; status: completed.
Beyond the preview
Go deeper on NCT02051348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02051348.